Treatment of botulism with guanidine. Early neurophysiologic studies.
D000200:Action Potentials / Q000187:drug effects; D000328:Adult; D000992:Antitoxins / Q000627:therapeutic use; D001905:Botulinum Toxins / Q000097:blood; D001906:Botulism / Q000188:drug therapy* / Q000503:physiopathology; D004576:Electromyography; D005260:Female; D006146:Guanidines / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009132:Muscles / Q000187:drug effects / Q000503:physiopathology; D009461:Neurologic Manifestations; D009469:Neuromuscular Junction / Q000187:drug effects; D009482:Neurophysiology
D000992:Antitoxins; D006146:Guanidines; D001905:Botulinum Toxins